EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris

Jan Holmback, Anders Carlsson, Puneet Rinwa

Journal of Drugs in Dermatology · 2023

DOI: 10.36849/jdd.7151 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Jan Holmback und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Psoriasis, Drug-Related Side Effects and Adverse Reactions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatologic AgentsPsoriasisDrug-Related Side Effects and Adverse ReactionsHumansOintmentsTreatment OutcomeCalcitriolEmollients

Substanzen

calcipotrieneDermatologic AgentsOintmentsCalcitriolEmollients

Zitieren

APA

Holmback, J., Carlsson, A., & Rinwa, P. (2023). Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7151

Vancouver

Holmback J, Carlsson A, Rinwa P. Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7151

BibTeX
@article{Holmback2023,
  author = {Holmback, Jan and Carlsson, Anders and Rinwa, Puneet},
  title = {Efficacy and Safety of Water-Free Lipid Formulation System Containing Calcipotriol Against Psoriasis Vulgaris},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  doi = {10.36849/jdd.7151}
}
Kostenlos starten →